https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.

administrator

Related Articles